Your browser doesn't support javascript.
loading
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.
Patel, Pritesh; Aydogan, Bulent; Koshy, Matthew; Mahmud, Dolores; Oh, Annie; Saraf, Santosh L; Quigley, John G; Khan, Irum; Sweiss, Karen; Mahmud, Nadim; Peace, David J; DeMasi, Vincenzo; Awan, Azhar M; Weichselbaum, Ralph R; Rondelli, Damiano.
Affiliation
  • Patel P; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois. Electronic address: prpatel8@uic.edu.
  • Aydogan B; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Cellular and Radiation Oncology, University of Chicago, Chicago, Illinois.
  • Koshy M; University of Illinois Cancer Center, Chicago, Illinois; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Cellular and Radiation Oncology, University of Chicago, Chicago, Illinois.
  • Mahmud D; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Oh A; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Saraf SL; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Quigley JG; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Khan I; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Sweiss K; Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois.
  • Mahmud N; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Peace DJ; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • DeMasi V; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Cellular and Radiation Oncology, University of Chicago, Chicago, Illinois.
  • Awan AM; Department of Cellular and Radiation Oncology, University of Chicago, Chicago, Illinois.
  • Weichselbaum RR; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Cellular and Radiation Oncology, University of Chicago, Chicago, Illinois.
  • Rondelli D; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois. Electronic address: drond@uic.edu.
Biol Blood Marrow Transplant ; 20(12): 2034-41, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25234438
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Transplantation Conditioning / Peripheral Blood Stem Cell Transplantation / Unrelated Donors Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Transplantation Conditioning / Peripheral Blood Stem Cell Transplantation / Unrelated Donors Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2014 Type: Article